CompletedNCT06650800
Psilocybin and reward processing in treatment-resistant depression
About this title
Read the official source — NCT06650800Medication studyAges 25–60France
Understand this study
Who was this study for?
Listed age limits: 25 years to 60 years.
- Listed locations
- NîmesSee all locations and recruitment
Study information
Study start dateStarted: November 19, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 10
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Not clearly listed
- Locations
- France
- Age range
- From 25 Years to 60 Years
- Official registry ID
- NCT06650800
- Official title
Show the full official title
Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Nîmes
Questions about this study
Who is behind this study?
The study sponsor is Centre Hospitalier Universitaire de Nīmes.
Did this study involve medication?
Yes. The study involved medication, including Psilocybin.
Who was this study for?
Listed age limits: 25 years to 60 years.
Want to explore more studies?
Explore studiesRelated studies
Intranasal Esketamine Added to Standard Care for Adults at Imminent Suicide Risk
A 24-Week, Flexible-Dose, Open-label Extension Study of Lurasidone for the Treatment of Bipolar I Depression